Cancer research is laced throughout all of Virginia Tech Carilion Research Institute’s focus areas. It is a formidable challenge. Cancer cells grow uncontrollably, and they evade even the most aggressive treatments. Researchers at the VTCRI are beginning to understand the molecular mechanisms underlying the genetic and environmental factors that encourage cancer growth, as well as how cancer multiplies and migrates throughout the body. With this new knowledge, researchers are developing methods to make cancer cells more vulnerable to existing treatments, as well as innovating completely new treatments in efforts to stop cancer and prevent it from recurring.
July 11, 2018
VTCRI scientist earns third concurrent grant from the National Cancer Institute to study breast cancer
Deb Kelly, an associate professor at the Virginia Tech Carilion Research Institute, was awarded $2.1 million by the National Cancer Institute (NCI) to study the ...
May 1, 2018
Cartledge Charitable Foundation joins fight against breast cancer with gift to Virginia Tech Carilion Research Institute
The Cartledge Charitable Foundation Inc. has joined the fight against breast cancer with a $100,000 gift to the Virginia Tech Carilion Research Institute. Positioned in ...
Jan. 25, 2018
A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer.
Sept. 7, 2018 1 p.m.
Sept. 28, 2018 1 p.m.
Oct. 4, 2018 5:30 p.m.